Redmile-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
56
Total Value
1057997904
Accession Number
0001104659-25-049578
Form Type
13F-HR
Manager Name
Redmile-Group
Data Enrichment
100% identified
56 identified0 unidentified

Holdings

56 positions • $1.1B total value
Manager:
Search and click to pin securities to the top
Page 3 of 3
Oruka Therapeutics, Inc.
Shares:387.0K
Value:$4.0M
% of Portfolio:0.4% ($4.0M/$1.1B)
IGM Biosciences, Inc.
Shares:3.0M
Value:$3.4M
% of Portfolio:0.3% ($3.4M/$1.1B)
CYTOKINETICS INC
Shares:82.1K
Value:$3.3M
% of Portfolio:0.3% ($3.3M/$1.1B)
4D Molecular Therapeutics, Inc.
Shares:997.2K
Value:$3.2M
% of Portfolio:0.3% ($3.2M/$1.1B)
PLIANT THERAPEUTICS, INC.
Shares:2.1M
Value:$2.8M
% of Portfolio:0.3% ($2.8M/$1.1B)
LAVA Therapeutics NV
Shares:2.1M
Value:$2.6M
% of Portfolio:0.2% ($2.6M/$1.1B)
Atara Biotherapeutics, Inc.
Shares:441.7K
Value:$2.6M
% of Portfolio:0.2% ($2.6M/$1.1B)
Xeris Biopharma Holdings, Inc.
Shares:451.1K
Value:$2.5M
% of Portfolio:0.2% ($2.5M/$1.1B)
ALX ONCOLOGY HOLDINGS INC
Shares:3.6M
Value:$2.3M
% of Portfolio:0.2% ($2.3M/$1.1B)
Repare Therapeutics Inc.
Shares:1.9M
Value:$1.9M
% of Portfolio:0.2% ($1.9M/$1.1B)
Ventyx Biosciences, Inc.
Shares:1.6M
Value:$1.8M
% of Portfolio:0.2% ($1.8M/$1.1B)
Astria Therapeutics, Inc.
Shares:269.1K
Value:$1.4M
% of Portfolio:0.1% ($1.4M/$1.1B)
Invivyd, Inc.
Shares:2.3M
Value:$1.4M
% of Portfolio:0.1% ($1.4M/$1.1B)
Boundless Bio, Inc.
Shares:725.2K
Value:$1.1M
% of Portfolio:0.1% ($1.1M/$1.1B)
Kalaris Therapeutics, Inc.
Shares:83.0K
Value:$666.1K
% of Portfolio:0.1% ($666.1K/$1.1B)
Allakos Inc.
Shares:856.6K
Value:$195.0K
% of Portfolio:0.0% ($195.0K/$1.1B)